Q32 Bio Inc. (QTTB)
QTTB trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$8.06
-7.78% on the day
Market cap
$239.9M
Micro cap
Revenue · 2025
$53.7M
Prior year not contiguous
Net income · 2025
$29.8M
55.5% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | QTTB on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2018 |
| SEC CIK | 0001661998 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $53.7M |
| Net income | $29.8M |
| Operating income | $16.9M |
| Net margin | 55.5% |
| Operating margin | 31.5% |
| Revenue growth | No prior-year revenue to compare |
| Cash | $48.3M |
| Total assets | $61.8M |
| P/E (computed) | 8.1× |
| P/S (computed) | 4.5× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2026-07-28 |
| Latest annual report | 10-K | 2026-03-10 |
| Latest quarterly / interim | 10-Q | 2026-08-05 |
| Latest current report | 8-K | 2026-09-30 |
| Latest proxy | DEFA14A | 2026-04-30 |
Source: SEC EDGAR submissions feed, 582 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| LFCR | Lifecore Biomedical Inc. | $6.42 | -0.31% | $243.0M |
| BBOT | BridgeBio Oncology Therapeutics Inc. Common Stock | $2.95 | -9.51% | $236.5M |
| ACIU | AC Immune SA | $2.40 | -2.04% | $244.3M |
| AMRN | Amarin Corporation plc | $11.58 | +0.43% | $244.6M |
| VOGX | Vogenx Inc | $16.76 | -2.22% | $249.0M |
| IMRX | Immuneering Corporation | $3.56 | -7.77% | $230.3M |
| IFRX | InflaRx N.V. | $1.55 | -2.52% | $228.4M |
| RCKT | Rocket Pharmaceuticals Inc. | $2.30 | -7.26% | $252.5M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier